Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

ORM-5029

Copy Product Info
🥰Excellent

Synonyms:

Catalog No. T210135 Copy Product Info
🥰Excellent
ORM-5029 is a human epidermal growth factor receptor 2 (HER2)-targeting antibody-drug conjugate (ADC) for cancer research, formed by conjugating the potent GSPT1 degrader SMol006 with Pertuzumab.

ORM-5029

Pack SizePriceUSA StockGlobal StockQuantity
1 mg$830-In Stock
5 mg$2,080-In Stock
10 mg$3,490-In Stock
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:98.53 (SEC-HPLC)
Appearance:Liquid
Color:Transparent
Contact us for more batch information

Product Introduction

Bioactivity
Description
ORM-5029 is a human epidermal growth factor receptor 2 (HER2)-targeting antibody-drug conjugate (ADC) for cancer research, formed by conjugating the potent GSPT1 degrader SMol006 with Pertuzumab.
In vivo
ORM-5029 (3 mg/kg or 10 mg/kg, intravenous injection, single dose) inhibited tumor growth in a dose-dependent manner in HCC1569, MDA-MB-453, and BT-474 xenograft models [1].
Chemical Properties
Molecular Weight152.59 kDa (Predicted)
Relative Density.no data available
Storage & Solubility Information
StorageKeep away from direct sunlight,Store at low temperature -20°C for 1 year Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: ORM-5029 in vivo | ORM-5029 molecular weight